PRQR
ProQR Therapeutics BV
1.70$
+0.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2,905.4% | -75.7% | -167.0% | – | -60.9% | -46.8% | +29.7% | +169.2% | +81.2% | +190.2% | -19.2% | |
| – | -97.3% | +165.4% | -21.9% | -1.8% | +11,778.2% | -98.1% | – | – | -94.6% | – | – | |
| – | +2,751.2% | -88.8% | -352.9% | – | -3,003.1% | – | +29.7% | +169.2% | +81.2% | +190.2% | -32.9% | |
| – | +127.9% | +36.4% | -2.4% | -5.3% | +57.5% | -18.0% | +10.7% | +20.5% | -50.6% | +44.6% | +12.0% | |
| – | +5.1% | +38.6% | +14.4% | +15.7% | +2.8% | +6.2% | +26.9% | +7.4% | -12.9% | -15.9% | +10.2% | |
| – | +80.3% | +36.9% | +1.4% | +0.1% | +41.2% | -26.9% | +34.9% | +17.4% | -44.2% | +28.7% | +11.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +49.1% | +36.2% | +10.8% | +35.9% | +33.7% | +88.4% | +66.9% | +50.6% | -76.5% | -10.5% | -19.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -50.0% | +13,100.0% | -6.1% | -5.6% | -17.9% | -181.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.